Price T Rowe Associates Inc ARRIVENT BIOPHARMA INC Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
Number of Shares
10,965
Previous 9,345
17.34%
Holding current value
$293,000
Previous $220,000
33.18%
% of portfolio
0.0%
Previous 0.0%